-
Microbot Medical Inc (NASDAQ: MBOT) shares
dropped 28.9 percent to $2.71. Microbot Medical reported a $10 million registered direct offering
-
ChinaCache International Holdings Ltd (NASDAQ: CCIH) shares dipped 17.6 percent to $1.39.
-
NewLink Genetics Corp (NASDAQ: NLNK)
fell 12 percent to $11.03 in pre-market trading after the company reported that indoximod + PROVENGE resulted in statistically
significant improvement in rPFS for patients with mCRPC in Phase 2 trial.
-
Juno Therapeutics Inc (NASDAQ: JUNO) shares
tumbled 8.6 percent to $23.95. Juno Therapeutics presented updated data from the TRANSCEND trial of JCAR017 at the ASCO Annual
Meeting.
-
Spi Energy Co Ltd (ADR) (NASDAQ: SPI) shares fell
8 percent to $1.39.
-
Endocyte, Inc. (NASDAQ: ECYT) shares declined 7.3
percent to $1.77. Cowen & Co. downgraded Endocyte from Outperform to Market Perform, while Wedbush downgraded the stock from
Outperform to Neutral.
-
Herbalife Ltd. (NYSE: HLF) shares slipped 6.3
percent to $69.24 after the company cut its sales forecast for the current quarter. Herbalife expects Q2 revenue to decline by
6 percent to 2 percent, and adjusted earnings of $0.95 to $1.15 per share.
-
Insys Therapeutics Inc (NASDAQ: INSY) shares
dropped 6.1 percent to $13.23 as the company issued a statement on negative media reports.
-
Perrigo Company plc (NYSE: PRGO) declined 5.7
percent to $69.29. RBC Capital downgraded Perrigo from Sector Perform to Underperform.
-
JinkoSolar Holding Co., Ltd. (NYSE: JKS) shares
dropped 3.5 percent to $18.12 after the company reported weaker-than-expected earnings for its first quarter.
-
CGG SA (ADR) (NYSE: CGG) shares fell 3.2 percent to
$6.61 after climbing 25.78 percent on Friday.
-
Keane Group Inc (NYSE: FRAC) declined 3 percent to
$15.12. Susquehanna initiated coverage on Keane Group with a Neutral rating.
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.